Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference7 articles.
1. A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin;Levy;Circulation,1993
2. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults;The Expert Panel;Arch Intern Med,1988
3. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II.);Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults;J Am Med Assoc,1993
4. Prevalence of high blood cholesterol among US adults: An update based on the guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel;Sempos;J Am Med Assoc,1993
5. Focus on fluvastatin-the first totally synthetic HMG-CoA reductase inhibitor for the treatment of hypercholesterolemia;Kellick;Hosp Formulary,1994